The Relation of Serum High-Sensitive C- Reactive Protein to Serum Lipid Profile, Vitamin D and Other Variables in a Group of Hypertensive Patients in Erbil-Iraq

Authors

  • Salam Naser Zangana

Keywords:

Hs-CRP, hypertension, lipid profile, vitamin D

Abstract

Abstract not found

How to Cite

The Relation of Serum High-Sensitive C- Reactive Protein to Serum Lipid Profile, Vitamin D and Other Variables in a Group of Hypertensive Patients in Erbil-Iraq. (2016). Global Journal of Medical Research, 16(27), 15-20. https://medicalresearchjournal.org/index.php/GJMR/article/view/

References

Robert OB, Douglas LM, Douglas PZ, Peter L (2011) Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.

Ministry of Health/Iraq, World Health Organization (2006) Chronic Non Communicable Diseases Risk Factors Survey in Iraq.

Blake GJ, Rifai N, Buring JE, Ridker PM (2003) Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events. 108, 2993-2999.

LiJian-jun (2005) Inflammation in hypertension: primary evidence. 119, 1215-1221.

Bautista LE, Atwood JE, O'Malley PG, Taylor AJ (2004) Association between C-reactive protein and hypertension in healthy middle-aged men and women. 15, 331-336.

Holick MF (2006) Prevalence of vitamin D inadequacy and implication for health. 81, 355-373.

Li YU, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1, 25-dihydroxyvitamin D3 is a negative endocrine regular of the rennin-angiotensin system. 110, 229-38.

Pauleto P, Rattazzi M (2006) Inflammation and hypertension: the search for a link. 21, 850-853.

E. Corrado, S. Novo (2005) Role of inflammation and infection in vascular disease. 105(6), 567-79.

(2015) Normal results.

Lloyd-Jones DM, Liu K, Tian L, Greenland P Assessment of C-reactive protein in risk prediction for cardiovascular disease. 145(1), 35-42.

National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. 6(2), 51-209. https://doi.org/10.1037/e565682010-001

A. Paul, Suzanne Barry, L. William, C. Cheryl, D. Joel, H. (2014) 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). 311(5), 507-520. https://doi.org/10.1001/jama.2013.284427

RM, M. Bierig, R. Devreux, F. Flachskampf, E. Foster, P. Pellikka (2005) Chamber Quantification Writing Group. Recommendations for Chamber Quantification: A report from the American Society of Echocardiography's) Group, Developed in conjunction with the Europian Association of Echocardiography, a branch of The European Society of Cardiology. 18, 1440-1463.

R. Devereux (1987) Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods.

Peter Okin, R. Devereux, S. Jer (2004) Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular Events. 292(19), 2343. https://doi.org/10.1001/jama.292.19.2343

Heike Bischoff-Ferrari, Edward Giovannucci, Walter Willett, Thomas Dietrich, Bess Dawson-Hughes (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. 84(1), 18-28. https://doi.org/10.1093/ajcn/84.1.18

Nader Rifai, G. Warnick Russell Warnick Lipids, lipoproteins, apolipoproteins and other cardiovascular risk factors Teitz text book of clinical chemistry. 26, 943-948.

Zheng L, Sun Z, Li J (2008) Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural areas of China. 39(7), 1932-7.

Ki Chul, Sung, Jung YulSuh, Bum Soo Kim (2003) High sensitivity C-reactive protein as an independent risk factor for essential hypertension. 16, 429-433.

Howard Sesso, J. Buring, N. Rifai (2003) C-Reactive Protein and the Risk of Developing Hypertension. 290(22), 2945. https://doi.org/10.1001/jama.290.22.2945

L. Bautista, L. Vera, I. Arenas, G. Gamarra (2005) Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension. 19(2), 149-154. https://doi.org/10.1038/sj.jhh.1001785

Sridevi Devaraj, Ishwarlal Dan yan xu (2003) Creactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells implications for the metabolic syndrome and atherothrombosis. 107(3), 398-404. https://doi.org/10.1161/01.cir.0000052617.91920.fd

Shu-Hong Chao-Hung Wang, Richard D (2003) C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle. 107, 1783-1790.

Rasouli M, Kiasari M (2006) Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease. 39(10), 971-977.

Richard Giovani de Simone, Marcello Devereux, Chinali (2006) Risk factors for Arterial Hypertension in adults with initial optimal blood pressure: the Strong Heart Study. 47(2), 162-167.

Mariana de, Marco, Giovanni de Simone, Mary Roman (2009) Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: The Strong Heart Study. 54, 974-980.

Abramson IL, Weintraub WS, Vaccariano V (2002) Association Between Pulse Pressure and C-Reactive Protein Among Apparently Healthy US Adults. 39(2), 197-202. https://doi.org/10.1161/hy0202.104270

Kampus P, Muda P, Kals J (2006) The relationship between inflammation and arterial stiffness in patients with essential hypertension. 112(1), 46-51. https://doi.org/10.1016/j.ijcard.2005.08.026

V. Vaccarino, Abramson Berger AK (2001) Pulse pressure and risk of cardiac events in the Systolic Hypertenion in the Elderly (SHE) program. 88(9), 980-986.

Blacher J, Staessen JA, Girerd X (2000) Pulse Pressure Not Mean Pressure Determines Cardiovascular Risk in Older Hypertensive Patients. 160(8), 1085. https://doi.org/10.1001/archinte.160.8.1085

Chae CU, Lee RT, Rifai N (2001) Blood Pressure and Inflammation in Apparently Healthy Men. 38(3), 399-403. https://doi.org/10.1161/01.hyp.38.3.399

Hensley K, Robinson KA, Gabbita SP (2000) Reactive oxygen species, cell signaling, and cell injury. 28, 1456-1462.

Y. Ding, J. wang, P. Zhang, P. Qu (2012) The realtion of serum high-sensitive C-reactive protein to risk factors and target organ damage in hypertensive patients. 98, 258-259.

Katarzyna S-S, Agnieszka O, Wiktoria W, Danuta C (2014) Association of serum vitamin D with left ventricular hypertrophy in hypertensive patients. 8(4), 65-66.

J. Lee (2008) Vitamin D deficiency an important, common, and easly treatable cardiovascular risk factor?. 52.

The Relation of Serum High-Sensitive C- Reactive Protein to Serum Lipid Profile, Vitamin D and Other Variables in a Group of Hypertensive Patients in Erbil-Iraq

Published

2016-08-15

How to Cite

The Relation of Serum High-Sensitive C- Reactive Protein to Serum Lipid Profile, Vitamin D and Other Variables in a Group of Hypertensive Patients in Erbil-Iraq. (2016). Global Journal of Medical Research, 16(27), 15-20. https://medicalresearchjournal.org/index.php/GJMR/article/view/